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Worldwide obesity rates have risen to pandemic levels, as the number of overweight and obese individuals has recently 
been estimated at 2.1 billion.1 Obesity has become a major 
cause of mortality,2 whereas obesity greatly increases the rela-
tive risk of death from cardiovascular disease (CVD).3 Impaired 
endothelium-dependent vasodilation is a key early step in ath-
erosclerotic progression and is predictive of future cardiovascu-
lar risk.4 Such impairments to microvascular resistance vessels 
lead to decreased capillary recruitment and have been shown to 
be exacerbated with increasing adiposity.5,6 Microvascular dys-
function is thought to contribute to the development of hyper-
tension because of increased peripheral vascular resistance7 and 
progression of insulin resistance by limiting nutrient and insulin 
delivery to skeletal muscle,8 both pathologies that could further 
compound CVD risk. Thus, obesity may promote microvascular 
dysfunction and the ensuing elevated cardiovascular risk.
Oxidative stress is a systemic feature of obesity that is well 
documented in clinical and experimental studies. Excessive reac-
tive oxygen species (ROS) production can result in apoptosis and 
increased cellular permeability, which may promote inflamma-
tion, endothelial dysfunction, and vascular remodeling.9 NADPH 
oxidase (Nox), in particular, is considered a prominent source 
of vascular-derived ROS and is known to promote endothelial 
dysfunction and play a pathophysiological role in hypertension, 
atherosclerosis, and diabetic microvascular complications.10 
Recently, we developed and validated a novel microdialysis 





) and superoxide.11 We developed this technique 
because direct measurement of oxidative stress in humans is 
extremely difficult, with investigators typically relying on indirect 
by-products of lipid peroxidation in plasma or urine,12 or from in 
vitro measurements of ROS production from excised tissue.13
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Objective—The objectives of this study were to determine the impact of in vivo reactive oxygen species (ROS) on 
microvascular endothelial function in obese human subjects and the efficacy of an aerobic exercise intervention on 
alleviating obesity-associated dysfunctionality.
Approach and Results—Young, sedentary men and women were divided into lean (body mass index 18–25; n=14), 
intermediate (body mass index 28–32.5; n=13), and obese (body mass index 33–40; n=15) groups. A novel microdialysis 




) and superoxide levels in the vastus lateralis 
of obese compared with both lean and intermediate subjects. Nutritive blood flow was monitored in the vastus lateralis via 
the microdialysis-ethanol technique. A decrement in acetylcholine-stimulated blood flow revealed impaired microvascular 










 levels were decreased in the obese subjects and microvascular endothelial function in these subjects was 
restored to levels similar to lean subjects. Skeletal muscle protein expression of the NADPH oxidase subunits p22phox, 
p47phox, and p67phox was increased in obese relative to lean subjects, where p22phox and p67phox expression was attenuated 
by exercise training in obese subjects.
Conclusions—This study implicates NADPH oxidase as a source of excessive ROS production in skeletal muscle 
of obese individuals and links excessive NADPH oxidase–derived ROS to microvascular endothelial dysfunction in 
obesity. Furthermore, aerobic exercise training proved to be an effective strategy for alleviating these maladies. 
(Arterioscler Thromb Vasc Biol. 2016;36:2412-2420. DOI: 10.1161/ATVBAHA.116.308339.)
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Aerobic exercise training has been found to promote 
far-reaching health benefits in multiple organ systems that 
extend well beyond reducing the traditional CVD risk fac-
tors.14 Aerobic interval training (AIT), in particular, has been 
shown to induce improvements in aerobic capacity, endothe-
lial function, and insulin signaling in patients with the meta-
bolic syndrome.15 Although exercise has been shown to induce 
ROS generation during exercise in an intensity- and duration-
dependent manner, the overall net effect of chronic exer-
cise training tends to promote a reduced oxidative burden.14 
Previous studies suggest that aerobic exercise training reduces 
oxidative stress and reverses endothelial dysfunction through 
an attenuation of Nox activity.16,17 Given the important path-
ological role of Nox-derived ROS, we sought to investigate 
the role of Nox in microvascular endothelial dysfunction in 
skeletal muscle of obese individuals and to determine whether 
aerobic exercise training mitigates this dysfunction by modu-
lating Nox or ROS scavenging. To accomplish these goals, we 
coupled our newly developed ROS measurement technique 
with our previously established microdialysis methodology 
of monitoring microvascular blood flow18,19 to simultaneously 
measure in vivo ROS levels and microvascular endothelial 
function in skeletal muscle of human subjects.
Materials and Methods




Subject characteristics are listed in Table 1. Body fat per-
centage was increased in the intermediate relative to the lean 
group (P<0.001) and the obese relative to the intermediate 
group (P=0.005). There were no group differences for fasting 
serum glucose levels; however, higher fasting insulin levels 
in the obese group (P=0.007) resulted in a higher HOMA-IR 
(homeostatic model of insulin resistance; P=0.014) compared 
with the lean group. Triglyceride levels seem higher in the 
intermediate than the obese group, although this trend did not 
reach statistical significance (P=0.265).
Subject characteristics before and after the exercise inter-
vention are listed in Table II in the online-only Data Supplement. 
None of the groups lost weight, nor were there any changes in 
body fat percentage or fasting glucose or insulin levels. AIT 
did not alter blood lipid profiles in the intermediate or obese 
groups, although training significantly reduced total (P=0.013) 
and low-density lipoprotein (P=0.007) cholesterol levels in the 
lean group. AIT increased VO
2peak
 in the intermediate (P=0.001) 
and obese (P<0.001) groups, although the increase in the lean 
group did not reach statistical significance (P=0.092).
Vascular Injury Markers
Pretraining serum markers of vascular injury are presented in 
Table 2. Serum concentrations of C-reactive protein (P=0.003), 
vascular cell adhesion molecule- (P=0.021), intracellular 
adhesion molecule-1 (P=0.044), E-selectin (P<0.001), and 
serum amyloid A (P=0.004) were higher in the obese rela-
tive to the lean group, with soluble intracellular adhesion mol-
ecule-3 higher in the obese relative to the intermediate group 
(P=0.015). There were no significant differences between the 
Nonstandard Abbreviations and Acronyms




ROS Reactive Oxygen Species
XO xanthine oxidase
Table 1. Pretraining Subject Characteristics and Metabolic 
Parameters
 Lean Intermediate Obese
Age, y 23.8±1.0 29.0±2.0* 25.0±1.2
Sex, M/F  5/9 7/6 3/12
Race, AA/C 2/12 4/9 7/8
Height, m 1.70±0.03 1.73±0.03 1.68±0.02
Weight, kg 63.3±3.5 91.3±3.4* 103.7±3.4*,†
BMI, kg/m2 21.6±0.6 30.1±0.4* 36.6±0.7*,†
Body fat, % 25.2±2.3 36.2±1.8* 46.0±1.2*,†
Glucose, mg/dL 86.1±2.4 91.7±1.9 89.7±1.8
Insulin, μIU/mL 7.1±0.8 14.1±3.5 18.7±2.9*
HOMA-IR 1.54±0.20 3.30±0.93 4.23±0.71*
Triglycerides, mg/dL 86.2±5.8 116±22.2 85.0±11.0
Cholesterol, mg/dL 160±8.1 161±6.1 154±8.6
HDL-C, mg/dL 57.3±3.7 42.8±3.8* 46.3±2.7
LDL-C, mg/dL 85.4±6.2 94.7±7.2 91.1±9.0
VO2peak, mL/kg per min 35.3±1.9 30.3±1.6 22.9±1.0*,†
AA/C indicates African American/Caucasian; BMI,  body mass index; HDL-C, 
high-density lipoprotein cholesterol; HOMA-IR, homeostatic model of insulin 
resistance; and LDL-C, low-density lipoprotein cholesterol.
*P<0.05 vs lean.
†P<0.05 vs intermediate.
Table 2. Pretraining Markers of Vascular Injury
 Lean Intermediate Obese
CRP, ng/mL 5.89±2.04 19.9±6.71 33.4±6.02*
VCAM-1, ng/mL 1.07±0.08 1.10±0.13 1.56±0.15*,†
ICAM-1, ng/mL 0.62±0.05 0.79±0.19 1.04±0.11*
sICAM-3, ng/mL 0.64±0.05 0.61±0.07 0.88±0.06†
E-selectin, ng/mL 5.69±2.10 13.0±2.93 20.0±2.06*
P-selectin, ng/mL 64.7±9.2 62.7±8.5 66.4±6.0
Thrombomodulin, ng/mL 3.77±0.46 3.36±0.41 3.47±0.15
SAA, ng/mL 12.4±3.8 16.0±4.6 36.0±5.8*,†
CRP indicates C-reactive protein; ICAM-1, intracellular adhesion molecule-1; 
SAA, serum amyloid A; sICAM-3, soluble intracellular adhesion molecule-3; and 
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intermediate and lean groups for any of the vascular injury 
markers. There were no AIT-induced changes for any vascular 







 was elevated in the obese group com-
pared with both the lean and intermediate groups (P<0.001; 
Figure 1). There were no significant differences across groups 
for ROS measured in the apocynin perfused probe; however, 




 only in the obese group 
(P<0.001). The increase in ROS signal on addition of super-
oxide dismutase to the perfusate, indicative of superoxide, 
was elevated in the obese group compared with both the lean 





 and superoxide in the obese group were inde-
pendent of sex and race of the participants in each group.
Microvascular Endothelial Function
Resting microvascular nutritive blood flow was not differ-
ent between any groups, nor was it significantly altered by 
apocynin perfusion (Figure 2A). Microvascular endothe-
lial function, tested by acetylcholine-stimulated blood flow, 
was attenuated in the obese relative to the lean (P=0.016) 
and intermediate (P=0.044) groups (Figure 2B), which was 
not dependent on the race or sex distribution of subjects in 
each group. Apocynin coperfusion augmented acetylcholine-
stimulated blood flow only in the obese group (P=0.041). 
Endothelium-independent vasodilatory function was tested by 
sodium nitroprusside–stimulated blood flow, which was not 
significantly different among any groups (Figure 2C).
Exercise Training Effects on ROS




 in the obese 
group (P=0.033), whereas the lean and intermediate groups 
were unchanged (Figure 3A). However, the increase in total 
ROS signal on superoxide dismutase perfusion was not sig-
nificantly changed by AIT in any group. Subtracting ROS 
concentrations measured in the apocynin perfused probe from 





 after AIT in the obese group (P=0.019; Figure 3B). ROS 
detected in the apocynin perfused probe revealed no AIT-
mediated changes in Nox-independent ROS (Figure 3C).
Exercise Training Effects on 
Microvascular Endothelial Function
Eight weeks of AIT did not alter resting nutritive skeletal mus-
cle blood flow in any group (Figure 4A), nor did it affect nutri-
tive blood flow under apocynin perfusion (Figure 4B). AIT 
Figure 1. In vivo NADPH oxidase–mediated reactive oxygen spe-
cies (ROS) in skeletal muscle of lean, overweight/mildly obese 
(Int), and obese subjects. ROS was measured without superoxide 
dismutase (−SOD) in the perfusate, indicative of H2O2 produced 
endogenously. ROS detected with SOD added (+SOD) to the 
perfusate is indicative of endogenous superoxide in addition to 
H2O2. ROS were also measured in the absence (−Apo) and pres-
ence of apocynin (+Apo), an NADPH oxidase inhibitor. Values are 
mean±SEM for n=13 to 15 subjects in each group. *P<0.05 vs 
lean group. †P<0.05 vs Int group. ‡Significant effect of apocynin 
(P<0.05). §Effect of SOD in obese significantly (P<0.05) greater 
than lean and Int groups.
Figure 2. Association between obesity and NADPH oxidase–
mediated skeletal muscle microvascular endothelial function.  
A, Basal microvascular blood flow was assessed in the absence 
(control) and presence (Apo) of apocynin in lean, overweight/
mildly obese (Int), and obese subjects. B, Microvascular endo-
thelial function was assessed as the change in blood flow from 
baseline (Δ blood flow) on the addition of acetylcholine (ACh) to 
the perfusate. C, Microvascular endothelium-independent blood 
flow was assessed by change in blood flow from baseline  
(Δ blood flow) on the addition of sodium nitroprusside (SNP) to 
the perfusate. Values are mean±SEM for n=13 to 15 subjects per 
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augmented microvascular endothelial function in the obese 
(P=0.033) but had no effect on the lean or intermediate groups 
(Figure 4C). There were no AIT-induced changes in apocy-
nin coperfused acetylcholine-stimulated blood flow in any 
group (Figure 4D). There were no AIT-mediated changes in 
endothelium-independent vasodilatory function in any group 
(Figure 4E).
Nox Subunit and Xanthine Oxidase 
Expression and Nox Activity
Representative images for Western blots ran against the Nox 
subunits gp91phox, p22phox, p47phox, p67phox, and xanthine oxi-
dase (XO) in skeletal muscle samples from a subset of lean, 
and obese subjects are presented in Figure 5A. Densitometry 
analysis revealed a trend (P=0.06) for increased gp91phox 
(Figure 5B) expression and significant (P<0.05) increases in 
expression for p22phox (Figure 5C), p47phox (Figure 5D), and 
p67phox (Figure 5E) in obese relative to lean subjects. AIT sig-
nificantly depressed p22phox and p67phox expression in obese 
subjects, although no AIT-induced changes were observed for 
gp91phox or p47phox expression. There were no obesity- or AIT-
induced changes observed in XO expression (Figure 5F). Nox 
activity was significantly elevated in sedentary obese versus 
lean skeletal muscle samples, where AIT-induced increased 
Nox activity in the lean tissue but suppressed Nox activity in 
obese tissue (Figure 5G).
Discussion
In this study, we utilized a novel microdialysis technique to 




 production are 
increased in skeletal muscle of obese relative to lean or over-
weight/mildly obese individuals. In addition, microvascular 
endothelial dysfunction was evident in these obese individu-
als relative to both of the other groups. A role for Nox in obe-
sity-associated oxidative stress and microvascular endothelial 
dysfunction was confirmed by 3 independent experiments, 
in that ROS production and endothelial dysfunction were 
attenuated by apocynin perfusion, that immunoblot analysis 
demonstrated increased expression of Nox subunits gp91phox, 
p22phox, p47phox, and p67phox in obese skeletal muscle, and that 
Nox activity was increased in obese skeletal muscle samples. 





levels and reversed microvascular endothelial dysfunction in 
obese individuals, which coincided with decreased expression 
of 2 of the 4 Nox subunits investigated and decreased ex vivo 
Nox activity.
Superoxide is a short-lived, highly reactive molecule 
with well-documented detrimental effects on vascular func-
tion driven by oxidative damage to lipids, proteins, and DNA, 
apoptosis, increased endothelial cell permeability, and quench-





, in contrast, is less reactive and, thus, more stable and 




 is critical for redox-
based signal transduction with several properties that may 




 activates several signaling 
cascades that modulate vascular function, including angiogen-
esis, endothelial barrier dysfunction and apoptosis, and induc-





 exposure has been found to impair endothelium-depen-
dent dilation of porcine coronary arterioles via induction of 
arginase activity.21 Hellsten et al22 have previously utilized a 
microdialysis approach based on cytochrome c reduction to 
demonstrate that superoxide levels are increased by exercise 
in human skeletal muscle. However, this study is the first to 




 and superoxide levels in vivo in 
human skeletal muscle and to demonstrate that both ROS are 
elevated in obese subjects.
A recent study by Walther et al23 demonstrated impaired 
brachial artery endothelial function and cutaneous microvas-
cular endothelial function in obese subjects with the metabolic 
syndrome. This study extends these findings to the lower limb 
skeletal muscle microvasculature and adds an important role 
Figure 3. Effect of exercise training on NADPH oxidase–mediated 
ROS production. ROS were measured before (Pre) and after 
(Post) 8 weeks of aerobic exercise training in lean, overweight/
mildly obese (Int), and obese individuals. A, ROS was measured 
without superoxide dismutase (−SOD) in the perfusate, indicative 
of H2O2 produced endogenously. ROS detected with SOD added 
(+SOD) to the perfusate is indicative of endogenous superoxide 
in addition to H2O2. B, NADPH oxidase (NOX)–mediated ROS 
were determined by calculation of the ROS that was inhibited 
by the NOX inhibitor apocynin (Apo). C, NOX-independent ROS 
were calculated as the fraction of ROS not inhibited by Apo. 
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for the degree of obesity, as subjects with a body mass index 
of 28 to 32.5 were free of microvascular endothelial dysfunc-
tion as opposed to subjects with a body mass index of 33 to 
40 in which microvascular endothelial dysfunction was evi-
dent. Recent large-scale population-based studies have con-
cluded that noninvasive assessment of vascular function in 
conduit vessels adds little predictive value to CVD risk above 
the traditional CVD risk factors, whereas the infusion of ace-
tylcholine into the resistance vasculature and assessment of 
vascular function in the resistance vessels improves CVD 
risk prediction beyond the Framingham risk score.24–26 These 
studies highlight the applicability of stimulating endothe-
lium-dependent dilation in the resistance vasculature for the 
assessment of cardiovascular health. In addition, 2 previous 
studies6,27 demonstrate that brachial artery endothelial func-
tion is augmented by the infusion of the antioxidant ascorbic 
acid in obese individuals, further demonstrating the detrimen-
tal nature of acute ROS production in the obese human vas-
culature. A stated limitation of one of these studies was that 
local, physiologically relevant levels of ROS were not detect-
able with the methods used in the study.27 The present study 





superoxide concentrations in the obese cohort, as well as by 
demonstrating improved endothelial function in the resistance 
vasculature in this cohort by drastically attenuating ROS lev-
els by apocynin perfusion, further implicating Nox as both a 
source of increased ROS and deterrent of vascular function in 
the resistance vasculature in the obese subjects. These find-
ings are further corroborated by the increased skeletal muscle 
p22phox, p47phox, and p67phox content and ex vivo Nox activity in 
the obese subjects.
The finding that sodium nitroprusside–stimulated blood 
flow was not different between any of the groups indicates 
that the impairment of acetylcholine-stimulated blood flow 
in the obese was indeed because of impaired endothelium-
dependent vasodilation, rather than the impairment of solu-
ble guanylate cyclase-mediated smooth muscle relaxation. 
Furthermore, the finding that impaired acetylcholine-stim-
ulated blood flow in the obese was reversed by apocynin 
perfusion implicates a role for Nox-mediated ROS in skel-
etal muscle microvascular endothelial dysfunction in human 
obesity. The observation that resting microvascular blood 
flow was not different between groups or altered by apocy-
nin suggests that the regulation of resting microvascular blood 
flow is also controlled by factors in addition to ROS and NO. 
Nonetheless, Nox-mediated ROS seem to be significantly 
affecting NO production in the obese group, which can have 
important ramifications on CVD development. Nox is a likely 
important source of vascular ROS in human obesity, as expres-
sion of Nox subunits are elevated in venous endothelial cells 
obtained from obese human subjects.28 Furthermore, Nox has 
previously been implicated in human vascular disease, as Nox 
Figure 4. Exercise training effects on 
skeletal muscle microvascular endothelial 
function. Microvascular blood flow was 
assessed before (Pre) and after (Post) 8 
weeks of aerobic exercise training in lean, 
overweight/mildly obese (Int), and obese 
subjects. A, Basal blood flow. B, Blood 
flow with apocynin perfusion. C, Micro-
vascular endothelial function, assessed 
by change in blood flow from basal  
(Δ blood flow) in response to acetyl-
choline perfusion. D, Effect of NADPH 
oxidase on microvascular endothelial 
function, assessed by change in blood 
flow on acetylcholine addition to the 
apocynin perfused probe. E, Microvascu-
lar endothelium-independent blood flow 
was assessed by change in blood flow 
from baseline on addition of sodium nitro-
prusside (SNP) to the perfusate. Values 
are mean±SEM for n=9 to 12 subjects per 
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activity and subunit expression have been found to be elevated 
in excised arterial segments from type II diabetic patients and 
coronary artery disease patients.29,30 In addition, apocynin 
perfusion through microdialysis probes has previously been 
found to blunt local angiotensin II–mediated vasoconstric-
tion in the human cutaneous microvasculature31 and to restore 
local cutaneous vascular conductance in chronic kidney dis-
ease patients.32 Thus, the findings in this study that apocynin 
delivery via microdialysis augments local microvascular func-
tion are not without precedent. Conversely, apocynin incuba-
tion has been shown to have no effect on flow-induced dilation 
in coronary resistance arteries from cardiopulmonary bypass 
patients.33 The finding that Nox-mediated ROS and micro-
vascular endothelial function were essentially unchanged in 
the overweight/mildly obese intermediate body mass index 
group relative to the lean group was unexpected and interest-
ing. This intermediate group demonstrated normal levels of 
vascular cell adhesion molecule-1, intracellular adhesion mol-
ecule-1, and soluble intracellular adhesion molecule-3, which 
were all elevated in the obese group. The discrepancy in these 
inflammatory and atherogenic molecules between the obese 
and overweight/mildly obese subjects could have long-term 
consequences of the accelerated development of more severe 
vascular pathologies in the obese. However, that acute apocy-
nin perfusion completely abrogated ROS levels and restored 
acetylcholine-stimulated blood flow implicates a more pro-
found role for Nox in driving the microvascular endothelial 
dysfunction observed in this obese group. It is important to 
note that these obese individuals were young and free of overt 
disease. As such, it is possible that more factors than ROS 
may be involved in regulating microvascular function in more 
severe disease states. These data also implicate an important 
role for the degree of obesity, as no functional abnormalities 
were observed in the overweight/mildly obese intermediate 
body mass index group. Nonetheless, this study demonstrates 
a critical, acute role for Nox-mediated ROS in regulating 
skeletal muscle microvascular endothelial function in obese 
individuals.
A recent meta-analysis concluded that a large proportion 
of the protective effects of exercise on the vasculature occur 
independent of changes in the traditional CVD risk factors 
and are more likely explained by the direct effects of exer-
cise on the arterial wall or cellular environment.34 In this 





 in the obese skeletal muscle extracellular 
environment post training. Despite no AIT-induced changes in 
the traditional cardiovascular risk factors, we observed aug-
mented microvascular endothelial function in the obese group, 
whereas apocynin no longer affected endothelial function post 
training. These AIT-induced changes were unique to the obese 
group, as neither the lean nor intermediate groups demon-
strated any changes in interstitial ROS levels or microvascular 
function post training. Previous studies suggest that exercise-
induced improvements in endothelial function are inversely 
Figure 5. Protein expression of NADPH oxidase subunits, xanthine oxidase (XO), and NADPH oxidase activity in lean and obese skel-
etal muscle. A, Representative Western blot images for NADPH oxidase subunits gp91phox, p22phox, p47phox, p67phox, and XO from skeletal 
muscle obtained from lean and obese subjects before (Pre) and after (Post) 8 weeks of aerobic exercise training. Images of α-tubulin are 
provided for a loading control. Densitometry analyses for (B) gp91phox, (C) p22phox, (D) p47phox, (E) p67phox, and (F) XO expression normalized 
to α-tubulin. G, NADPH-stimulated H2O2 generation was measured as an index of NADPH oxidase activity. Values are mean±SEM for n=5 
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proportional to pretraining functionality.34 Given that the lean 
and intermediate groups demonstrated large pretraining vaso-
dilatory responses to acetylcholine, failure to improve further 
was unsurprising. However, exercise-induced reversal of endo-
thelial dysfunction through attenuation of Nox-derived ROS 
has been implicated in several contexts.16,35–37 Exercise training 
has been shown to decrease Nox activity or subunit expres-
sion in coronary arteries of diet-induced obese rodents36,37 and 
carotid arteries of aged rodents,35 whereas apocynin improves 
endothelial function in sedentary but not exercise trained ves-
sels in these studies. Importantly, patients with CAD who 
performed 4 weeks of aerobic exercise training before bypass 
surgery demonstrated reduced Nox activity and increased 
vasodilatory function in internal mammary artery segments 
relative to patients who remained sedentary before surgery.16 
These findings demonstrate an ability of Nox activity to be 
beneficially altered in severely diseased human arteries by rel-
atively short-term exercise training.16 This study adds to these 
findings by demonstrating an ability of exercise training to act 
in a restorative manner and reverse endothelial dysfunction in 
the lower limb microvasculature of the obese individuals, even 
those without overt vascular or metabolic disease.





induced by AIT in the obese is supported by AIT-induced 
decreases in p22phox and p67phox protein content and ex vivo 
Nox activity in skeletal muscle tissue in a subset of these 
subjects. Aside from Nox, there are several factors that could 
potentially influence interstitial ROS levels. It is possible 





detoxification pathways in the obese, such as the glutathi-
one and thioredoxin systems, catalase, and the Nrf2/Keap1 




 has a longer half-life 
and is much more membrane permeable than superoxide, it 




 detected via microdialysis 
is mitochondria derived. In this context, it is also likely that 
exercise training in the obese subjects promotes a reduction 
in mitochondrial-derived ROS emission, which could mani-




. We have previously demon-




 emission in 
red gastrocnemius of high-fat, high sucrose-fed rats through 
an upregulation of the thioredoxin system.39 In addition, Gram 





 emission in skeletal muscle biopsy 
samples from subjects who had previously undergone leg 
immobilization. Importantly, excessive mitochondrial-derived 
ROS has been found to promote endothelial dysfunction.40,41 
There also remains a possibility that Nox-derived ROS stimu-
lates mitochondrial ROS production.42 Mitochondrial ROS 
production from Nox-overexpressing transgenic mice fed a 
high-fat diet is increased 3-fold over wild-type mice fed the 
same high-fat diet.43 Thus, it remains possible that apocynin 
perfusion attenuates mitochondrial ROS production through 
the inhibition of ROS-induced ROS release. In addition, syn-
ergy between Nox- and XO-derived ROS has been demon-
strated, whereby Nox inhibition prevents XO activation.44 
Both mitochondrial ROS and XO activity have been shown 
to be increased in nondiabetic obese subjects relative to lean 
counterparts.45,46 Regardless of the enzymatic source of ROS, 









 after exercise training in the obese group, 
which coincided with improved microvascular endothelial 
function in these individuals.
Apocynin was the only Nox inhibitor used in this study; 
thus, all inferences made on the microvascular effects of 
Nox are derived from the influence of apocynin. Apocynin is 
reported to inhibit the assembly of p47phox and p67phox within 
the membrane complex and the activation of NADPH oxidase 
isoforms that require subunit translocation.47 However, apocy-
nin has been reported to be both an antioxidant48 and a pro-oxi-
dant.49 Thus, we cannot be certain that the effects of apocynin 
were mediated specifically through Nox inhibition. All of the 
ROS measurements from the apocynin perfused probe were 









 standard curve constructed in the apocynin-containing 




 scavenging effect of apoc-
ynin or any possible interference of apocynin on the amplex 
ultrared assay would be accounted for by the standard curve. 
The marked inhibition of ROS by apocynin strongly suggests 
that apocynin does not have a pro-oxidant effect in this sys-
tem. Despite the potential limitations of apocynin, it is by far 
the most commonly used Nox inhibitor available,31,32,35,37,40 and 
at the concentrations used by use in these studies, it is unreal-
istic to expect that any potential antioxidant effect of this com-
pound could explain the effects observed here. A few subjects 
from each group dropped out of the exercise program before 
completion; thus, data were not attained from these subjects 
for post-training measures. In addition, the muscle biopsy was 
an optional procedure to which only 5 subjects per group con-
sented. Despite the small sample size, the marked elevation 
in Nox activity and expression of Nox subunits in the obese 
subjects conferred clear differences that were statistically sig-
nificant. Furthermore, the obese subjects failed to lose weight 
in response to exercise training. There were no improvements 
in traditional cardiometabolic risk factors or inflammatory 
markers after exercise training, although there is evidence to 
suggest that weight loss is necessary for a reduction in fasting 
glucose, triglyceride, or cholesterol levels.50,51 High-intensity 
exercise has been shown to induce an acute proinflammatory 
state, which may last for ≤72 hours after intense exercise.52 
Thus, any long-term anti-inflammatory effects of the exercise 
program could be masked by blood sampling 48 hours after 
the final exercise bout. It is noteworthy that exercise training 
altered the ROS levels, Nox activity and expression levels, and 
microvascular endothelial function without improvements in 
any of these inflammatory or traditional risk factors, which 
highlights the beneficial effects of exercise in the obese popu-
lation, which extend well beyond these markers.
In conclusion, we demonstrate for the first time that in 
vivo ROS are elevated in skeletal muscle of obese human sub-
jects. This study is the first utilization of the newly developed 





ide11 and is the first demonstration of increased in vivo ROS 
in human skeletal muscle under a pathological condition. 
Perfusion of apocynin normalized ROS levels and reversed 
microvascular endothelial dysfunction in obese subjects, pro-
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function in the in vivo setting. In addition, AIT was proven 




 and reversing microvascu-
lar endothelial dysfunction in the obese cohort, providing fur-
ther evidence that AIT is a practical, clinically relevant means 
to alleviate these obesity-associated maladies. Furthermore, 
these obese subjects were young with normal blood chem-
istries of the traditional clinically evaluated cardiometabolic 
risk factors, although they were likely in an early state of 
CVD pathogenesis as evidenced by microvascular endothelial 
dysfunction. This study implicates Nox-mediated ROS as a 
potential target to prevent further CVD progression in obesity.
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Highlights
•	 A novel technique to directly measure in vivo H2O2 and superoxide revealed increased levels of both ROS in obese human subjects relative to 
lean and overweight/mildly obese subjects.
•	 Microvascular endothelial function was impaired in obese relative to lean and overweight/mildly obese subjects.
•	 NADPH oxidase inhibition normalized H
2O2 and superoxide levels and reversed endothelial dysfunction in the obese subjects.
•	 Eight weeks of aerobic exercise training decreased H2O2 levels and improved microvascular endothelial function in the obese subjects.
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